Correlation Between Fortress Biotech and Spero Therapeutics

Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fortress Biotech Pref and Spero Therapeutics, you can compare the effects of market volatilities on Fortress Biotech and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Spero Therapeutics.

Diversification Opportunities for Fortress Biotech and Spero Therapeutics

0.16

Correlation Coefficient

Fortress Biotech  Spero Therapeutics

Average diversification

The 3 months correlation between Fortress and Spero is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech Pref and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech Pref are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Fortress Biotech and Spero Therapeutics

Assuming the 90 days horizon Fortress Biotech Pref is expected to generate 0.77 times more return on investment than Spero Therapeutics. However, Fortress Biotech Pref is 1.29 times less risky than Spero Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  673.00  in Fortress Biotech Pref on December 5, 2024 and sell it today you would lose (111.00) from holding Fortress Biotech Pref or give up 16.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fortress Biotech Pref  vs.  Spero Therapeutics

Fortress Biotech Pref

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fortress Biotech Pref has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Preferred Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Spero Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Fortress Biotech and Spero Therapeutics

The main advantage of trading using opposite Fortress Biotech and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.

The idea behind Fortress Biotech Pref and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.